Toronto Western Hospital
Toronto, Ontario MST 258
12 studies enrolling now · 103 studies all time
What they study most
Active Systemic Lupus Erythematosus, Acute Ischemic Stroke, Acute Kidney Injury, Acute Respiratory Failure, Adult Spinal Deformity, Advanced Parkinson's Disease, Alzheimer Disease, Alzheimer's Disease, Alzheimers Disease, Alzheimer´s Disease, Anaplastic Astrocytoma, Ankle and Hindfoot Arthrodesis
Studies at this site
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
- International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF) — Recruiting now
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI — Recruiting now
- Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study — Recruiting now
- Primary Tumor Research and Outcomes Network — Recruiting now
- Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH) — Recruiting now
- Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Recruiting now
- Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Running, not enrolling
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Enrolling by invitation
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease — Running, not enrolling
- A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 — Completed
- ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease — Running, not enrolling
- Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
- Study to Evaluate Cerebral AneurysmFlow Results in Occlusion — Completed
- Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease — Completed
- Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis — Completed
- Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol. — Completed
- A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
- A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
- A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
- ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease — Completed
- Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease — Completed
- Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. — Completed
- Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial) — Completed
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease — Completed
- EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
- Noninterventional Study Evaluating Parkinson's Disease Diary Use — Running, not enrolling
- Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early
- Regional Versus General Anesthesia for Promoting Independence After Hip Fracture — Completed
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 — Enrolling by invitation
- Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
- Prospective Evaluation of Elderly Deformity Surgery — Completed
- A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed
- Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis — Completed
- Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
- A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease — Paused
- An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis — Stopped early
- Post-market Assessment of Biodesign Dural Repair Grafts — Completed
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
- A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
- CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early